The Role of ATRX in Glioma Biology
- PMID: 29034211
- PMCID: PMC5626857
- DOI: 10.3389/fonc.2017.00236
The Role of ATRX in Glioma Biology
Abstract
The current World Health Organization classification of CNS tumors has made a tremendous leap from past editions by incorporating molecular criteria in addition to the pre-existing histological parameters. The revised version has had a particular impact on the classification of diffuse low-grade gliomas and their high-grade variants. The ATRX status is one of the critical markers that define the molecular classification of gliomas. In this review, we will first provide an overview of the role of ATRX in regular cell biology. Furthermore, the role of ATRX in tumorigenesis, specifically gliomas, is comprehensively elucidated. The possible correlation of ATRX status with other genetic/epigenetic modifications is also presented. We conclude by discussing some of the challenges associated with incorporating ATRX status assessment into routine clinical practice while also exploring opportunities for future diagnostics/therapeutics in gliomas based on ATRX status.
Keywords: ATRX; IDH; astrocytoma; glioma; oligodendroglioma.
Figures
Similar articles
-
[Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors. German version].Pathologe. 2019 Mar;40(2):131-139. doi: 10.1007/s00292-019-0575-6. Pathologe. 2019. PMID: 30790013 Review. German.
-
Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors.Pathologe. 2019 Jun;40(Suppl 1):9-17. doi: 10.1007/s00292-019-0581-8. Pathologe. 2019. PMID: 31025086 Review. English.
-
IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.Oncotarget. 2015 Oct 6;6(30):30295-305. doi: 10.18632/oncotarget.4497. Oncotarget. 2015. PMID: 26210286 Free PMC article.
-
ATRX immunohistochemistry can help refine 'not elsewhere classified' categorisation for grade II/III gliomas.Br J Neurosurg. 2019 Oct;33(5):536-540. doi: 10.1080/02688697.2019.1600657. Epub 2019 Apr 24. Br J Neurosurg. 2019. PMID: 31018710
-
DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.Clin Epigenetics. 2017 Apr 4;9:32. doi: 10.1186/s13148-017-0331-9. eCollection 2017. Clin Epigenetics. 2017. PMID: 28392842 Free PMC article.
Cited by
-
Potential Diagnostic Value of the Differential Expression of Histone H3 Variants between Low- and High-Grade Gliomas.Cancers (Basel). 2021 Oct 20;13(21):5261. doi: 10.3390/cancers13215261. Cancers (Basel). 2021. PMID: 34771425 Free PMC article.
-
Systematically Dissecting the Function of RNA-Binding Proteins During Glioma Progression.Front Genet. 2020 Jan 28;10:1394. doi: 10.3389/fgene.2019.01394. eCollection 2019. Front Genet. 2020. PMID: 32047515 Free PMC article.
-
Alpha thalassemia/mental retardation X-linked (ATRX) protein expression in human pituitary neuroendocrine tumours and its reported correlation to prognosis and clinical outcomes: A systematic review.PLoS One. 2025 May 29;20(5):e0313380. doi: 10.1371/journal.pone.0313380. eCollection 2025. PLoS One. 2025. PMID: 40440300 Free PMC article.
-
The advanced development of Cx43 and GAP-43 mediated intercellular networking in IDH1 wildtype diffuse and anaplastic gliomas with lower mitotic rate.J Cancer Res Clin Oncol. 2021 Oct;147(10):3003-3009. doi: 10.1007/s00432-021-03711-6. Epub 2021 Jun 26. J Cancer Res Clin Oncol. 2021. PMID: 34173871 Free PMC article.
-
Mutation-based clustering and classification analysis reveals distinctive age groups and age-related biomarkers for glioma.BMC Med Inform Decis Mak. 2021 Feb 27;21(1):77. doi: 10.1186/s12911-021-01420-1. BMC Med Inform Decis Mak. 2021. PMID: 33639927 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous